Top-News

Medicines News

Keine aktuellen Kursdaten verfügbar
WKN: 938858
ISIN: US5846881051
US-Symbol: MDCO
Typ: Aktie

Medicines News

25.04.22 - Newsfile
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
New York, New York--(Newsfile Corp. - April 25, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. ...
23.04.22 - Newsfile
ROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
New York, New York--(Newsfile Corp. - April 23, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. ...
16.04.22 - Newsfile
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Homology Medicines, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
New York, New York--(Newsfile Corp. - April 16, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. ...
15.04.22 - Newsfile
FIXX INVESTOR NOTICE: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
New York, New York--(Newsfile Corp. - April 15, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. ...
12.04.22 - Newsfile
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
New York, New York--(Newsfile Corp. - April 12, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. ...
15.02.22 - ACCESSWIRE
Jaguar Health Announces Receipt by Napo Therapeutics of Small and Medium Enterprise (SME) Designation from the European Medicines Agency
SME status is an important designation for Italy-​based Napo Therapeutics' rare/orphan disease business model
27.01.22 - PLX
Pfizer Covid-19 Oral Treatment Paxlovid Gets Positive Opinion from European Medicines Agency
(PLX AI) – Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment. • Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
13.12.21 - ACCESSWIRE
European Medicines Agency Grants Orphan Drug Designation for Crofelemer to Napo EU, Jaguar Health’s Italian Subsidiary, for Short Bowel Syndrome
The recognition of Orphan Drug Designation in Europe for crofelemer for this rare disease is the first key milestone of Napo EU under the company's exclusive license agreement ...
23.11.21 - Newsfile
Innovative Medicines Canada and Roche Canada Announce Scholarship for the University of Toronto's Dalla Lana School of Public Health
Ottawa, Ontario--(Newsfile Corp. - November 23, 2021) - Innovative Medicines Canada (IMC) and Hoffmann-​La Roche Limited (Roche Canada) today announced a $50,000 ...
15.09.21 - ACCESSWIRE
Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
The conditional marketing authorization pathway in Europe for crofelemer for this orphan disease is the initial focus of Napo EU under the license agreement between Napo EU and ...
20.07.21 - PR Newswire
Everest Medicines Announces Strategic Collaboration with MediTrust Health Co., Ltd to Develop Novel Payment Solutions for Patients in China
Everest Medicines Announces Strategic Collaboration with MediTrust Health Co., Ltd to Develop Novel Payment Solutions for Patients in China PR Newswire
13.07.21 - PR Newswire
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China Collaboration ...
12.07.21 - PR Newswire
Everest Medicines Announces Strategic Commercial Partnership with Global Technology Company, Tencent
Everest Medicines Announces Strategic Commercial Partnership with Global Technology Company, Tencent Partnership will enable Everest Medicines to leverage the power of ...
07.07.21 - PR Newswire
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
23.06.21 - Newsfile
Patented Medicine Prices Review Board Risks Harming the Health of Canadians by Reducing Access to New Medicines
Ottawa, Ontario--(Newsfile Corp. - June 23, 2021) - On June 21, Innovative Medicines Canada (IMC) submitted six recommendations to the federal government as part of the ...
16.06.21 - PR Newswire
FDA Approves Blueprint Medicines' AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
FDA Approves Blueprint Medicines' AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis -- First precision therapy that specifically targets the ...
04.06.21 - PR Newswire
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
27.05.21 - PR Newswire
ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company
ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company PR Newswire
26.05.21 - PR Newswire
NRx Pharmaceuticals to Lead Development of COVID-19 Medicines and Vaccines in Central Europe and the Caucasus Region in Collaboration with the Lugar Institute and Cromos Pharma
NRx Pharmaceuticals to Lead Development of COVID-19 Medicines and Vaccines in Central Europe and the Caucasus Region in Collaboration with the Lugar Institute and Cromos ...
25.05.21 - PR Newswire
Blueprint Medicines to Present at Upcoming Investor Conferences
Blueprint Medicines to Present at Upcoming Investor Conferences PR Newswire

Newssuche

Videos

newspaper
18.04.24
Technical Trading: Gold mit weiterem Potenzial
Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »